Medilife
Medilife Srl, commonly referred to as Medilife, is a prominent player in the healthcare industry, headquartered in Italy. Founded in 2005, the company has established itself as a leader in the development and distribution of innovative medical devices and healthcare solutions, primarily serving the European market and expanding its reach globally. Medilife's core offerings include advanced diagnostic tools, surgical instruments, and patient monitoring systems, all designed to enhance clinical outcomes and improve patient care. What sets Medilife apart is its commitment to quality and innovation, ensuring that all products meet stringent regulatory standards while incorporating the latest technological advancements. With a strong market position, Medilife has achieved notable milestones, including several industry awards for excellence in product design and functionality. The company continues to drive progress in the healthcare sector, making significant contributions to medical technology and patient safety.
DitchCarbon Score
How does Medilife's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medilife's score of 8 is higher than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medilife's reported carbon emissions
In 2023, Medilife reported total carbon emissions of approximately 2,302,000 kg CO2e, with Scope 1 emissions at about 394,000 kg CO2e and Scope 2 emissions reaching approximately 1,908,000 kg CO2e. This marks an increase from 2022, where total emissions were about 2,089,000 kg CO2e, with Scope 1 at approximately 412,000 kg CO2e and Scope 2 at around 1,677,000 kg CO2e. In 2021, the total emissions were approximately 1,960,000 kg CO2e, with Scope 1 emissions of about 398,000 kg CO2e and Scope 2 emissions of approximately 1,562,000 kg CO2e. Despite the rising emissions, Medilife has not publicly disclosed specific reduction targets or initiatives aimed at mitigating their carbon footprint. The absence of defined climate pledges or science-based targets suggests a need for enhanced commitment to sustainability practices within the organisation. As the healthcare industry increasingly prioritises climate action, Medilife's future strategies will be crucial in aligning with global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 398,000 | 000,000 | 000,000 |
| Scope 2 | 1,562,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Medilife is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
